East palestine Residents' DNA under microscope after toxic train wreck
NCT ID NCT06357845
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether the chemicals released during the 2023 train derailment in East Palestine, Ohio caused DNA damage in local residents. About 500 people from affected counties will give blood, spit, hair, or nail samples and answer a survey. The goal is to measure biological changes linked to the disaster and understand how proximity and health history affect risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 500 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2024
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Residence on February 3rd, 2023 in Columbiana County, Ohio, Mahoning County, Ohio, Beaver County, PA, or Lawrence County, PA. * Current residence in the United States. Exclusion Criteria: * Address provided for February 3rd, 2023 not in Columbiana County, Ohio, Mahoning County, Ohio, Beaver County, PA, or Lawrence County, PA * Invalid address provided for February 3rd, 2023 residence.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Somatic mutation are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Case Western Reserve University, Case Comprehensive Cancer Center
RECRUITINGCleveland, Ohio, 44195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New stem cell transplant aims to cut dangerous side effects in blood cancer patients
- Scientists decode DNA of rare eye tumors to track Cancer's moves
- Scientists hunt for hidden genes behind mysterious fevers
- Twin study seeks genetic clues to childhood brain cancer
- 50,000 samples to unlock secrets of hereditary tumors